Radboud University Medical Centre
Novigenix to Develop Prostate Cancer Liquid Biopsy Test With €1.8M Eurostars Consortium Grant
The company is working with investigators at Radboud University to validate an RNA liquid biopsy test to better tailor therapy in advanced castration-resistant prostate cancer.
Predica Diagnostics Developing Targeted Sequencing Test for Cervical Cancer Diagnosis, Screening
Premium
The test is based on targeted circular probe-based RNA next-generation sequencing (ciRNAseq), which enables a high degree of multiplexing and mutational analysis.
MGI Tech, Predica Diagnostics Partner to Develop RNA-Based Cancer Screening Tests
The companies will combine Predica’s proprietary circular probe-based RNA-seq technology with MGI’s DNBSeq platforms for early cancer detection.
In a trial of 23 Lynch syndrome patients, those who received the vaccine and developed neoantigen-specific T cells had a higher chance of remaining disease-free over 10 years.
Head Size-Related Genetic Variants Coincide With Cancer Genes, Pathways
A large genome-wide association study meta-analysis uncovered dozens of head size-linked loci, including sites that overlapped with macrocephaly and cancer-related genes and processes.